Navigation Links
Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2
Date:5/23/2013

s muestran que las observaciones anteriores se pueden replicar de forma prospectiva, y que una aproximación híbrida iFR/FFR puede proporcionar un acuerdo superior a un 90% con FFR al tiempo que ahorra el uso del agente hiperémico en más de la mitad de los pacientes".

Los resultados de ADVISE II reproducidos antes de las publicaciones retrospectivas iFR® demostraron que el uso del flujo de trabajo Hybrid iFR®/FFR proporcionó un acuerdo de clasificación general con un FFR en más del 90% de los pacientes que participaron en el estudio, a la vez que evitó a más del 50% de dichos pacientes la administración de fármacos hiperémicos. De hecho, el análisis preliminar mostró un 91,5% de acuerdo con FFR y un 71,5% de ahorros de fármacos hiperémicos por lesión. Los pacientes de ADVISE II fueron reclutados de más de 40 centros de Estados Unidos y Europa, y todos los análisis fueron realizados con operadores a ciegas de valores iFR® que fueron calculados offline en un laboratorio central independiente en Rótterdam, Países Bajos.

También se presentaron esta semana los primeros 392 casos en tiempo real desarrollados en vivo en el cath lab de más de 20 centros de Europa, Japón y Sudáfrica que están ahora equipados con el software iFR®. Esos resultados confirmaron los resultados anteriores y los resultados preliminares ADVISE II presentados en EuroPCR.

"Después de usar iFR en la práctica clínica mundial, su simplicidad es claramente su fortaleza. En un cath lab ocupado, ahorrar tiempo es importante y los resultados en mi experiencia han sido consistentes y útiles clínicamente", comentó Andrew Sharp , MD, Interventional Cardiologist del Royal Devon & Exeter Hospital, Exeter, Reino Unido. "Una vez
'/>"/>

SOURCE Volcano Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Volcano Corporation Presentation At JMP Securities Conference To Be Webcast
2. Volcano to Highlight its Leadership in Precision Guided Therapy at EuroPCR 2012
3. Volcano Corporation Presentation At Jefferies Conference To Be Webcast
4. Volcano Corporation Presentation at Wells Fargo Conference to be Webcast
5. Volcano Corporation Schedules Second Quarter Conference Call, Webcast
6. Volcano Corporation Reports 13 Percent Growth In Second Quarter Revenues; FFR Disposable Revenues Increase 38 Percent
7. Volcano Corporation Presentation At Canaccord Genuity Conference To Be Webcast
8. FAME 2 Published in the New England Journal of Medicine, Volcano participates in the $84M NIH-Sponsored ISCHEMIA Trial
9. Volcano Corporation Presentation At Stifel Nicolaus Conference To Be Webcast
10. Volcano Announces Previous St. Jude Medical Products Infringe Volcano Patent and Jury Verdicts in Patent Trials with St. Jude Medical
11. Volcano Corporation Schedules Third Quarter Conference Call, Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... , Aug. 3, 2015 Immune Pharmaceuticals, Inc. ... Dr. Daniel Teper , will present live at ... 6, 2015 TIME:   11:30AM EDT LINK:    http://tinyurl.com/aug6-pre-imnp ... interactive online event where investors are invited to ask ... presentation hall as well as the association,s "virtual trade ...
(Date:8/3/2015)... SAN DIEGO , Aug. 3, 2015  Sorrento ... that it has entered into an exclusive licensing agreement ... or biobetter antibodies from Mabtech Limited, a holding company ... China . Under the ... these 4 monoclonal antibodies (mAbs) for the North American, ...
(Date:7/31/2015)... , July 31, 2015  In today,s ever-changing marketplace, ... are increasingly mobile, increasingly connected, and increasingly impatient with ... of customer interaction channels and tools is driving call ... media. According to research by benchmarking ... counter (OTC) segment in a call center study realize ...
Breaking Medicine Technology:Immune Pharmaceuticals to Webcast Live at VirtualInvestorConferences.com August 6 2Sorrento In-Licenses Four Late-Stage Clinical Biobetter and Biosimilar Antibodies 2Sorrento In-Licenses Four Late-Stage Clinical Biobetter and Biosimilar Antibodies 3Sorrento In-Licenses Four Late-Stage Clinical Biobetter and Biosimilar Antibodies 4Best Practices in Building World-Class Consumer & Over-the-Counter Call Centers 2
... , ABBOTT PARK, Ill., July 28 ... Food and Drug Administration (FDA) approval for two new ... SIMCOR dosage strengths combine 40 mg of simvastatin – ... either 500 mg or 1,000 mg of niacin extended-release. ...
... In FDLI,s latest monograph, Selling Pharmaceuticals and Biologics to ... , Joy Sturm , Allison Pugsley ... Hogan Lovells US LLP detail how pharmaceutical and ... price calculation requirements. The 73-page monograph (Volume 1, #5) succinctly ...
Cached Medicine Technology:Abbott's SIMCOR ® ( niacin extended-release / simvastatin ) Receives FDA Approval for New Dosage Strengths 2Abbott's SIMCOR ® ( niacin extended-release / simvastatin ) Receives FDA Approval for New Dosage Strengths 3New FDLI Monograph Provides Expert Guidance on Selling Pharmaceuticals, Biologics to Federal Government 2
(Date:8/3/2015)... ... August 03, 2015 , ... Bodybuilding.com, ... of nutritional supplements, has officially opened the polls for their eleventh annual ... following categories:, ,     Brand of the Year (BPI Sports) ...
(Date:8/3/2015)... , ... August 03, 2015 , ... The art of ... Learning from her grandmother’s side at a young age, Nasreen Zereshki was extremely eager ... decided to share her cookbook Recipes from My Persian Kitchen with the world. , ...
(Date:8/3/2015)... ... August 03, 2015 , ... It’s ... Ahjumawi Lava Springs, California’s northernmost and among its least visited State Parks. The ... aquifers, whose main outflow is at Ahjumawi Lava Springs, part of the Fall ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... ... is predicted to decline by 39 percent, according to market research compiled for ... includes data from the U.S. Department of Labor, Bureau of Labor Statistics. As ...
(Date:8/3/2015)... ... 03, 2015 , ... Constantin Vasilica, 48 from Romania wanted to have an ... after many years of suffering and using medications with strong side effects. This had ... for extra time off or wait longer hours in the waiting rooms. Instead, he ...
Breaking Medicine News(10 mins):Health News:BPI Sports is Nominated for 11 Different 2015 Bodybuilding.com Supplement Awards 2Health News:BPI Sports is Nominated for 11 Different 2015 Bodybuilding.com Supplement Awards 3Health News:Persian Cuisine: Colorful and Extremely Healthy 2Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 2Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 3Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 4Health News:Dental Association Announces Impending Reduction of Dental Laboratories Could Impact Dentists 2Health News:Dental Association Announces Impending Reduction of Dental Laboratories Could Impact Dentists 3Health News:Chinese Health Care Provider Heshoutang Now Give Patients Complimentary Online Healing Options 2Health News:Chinese Health Care Provider Heshoutang Now Give Patients Complimentary Online Healing Options 3
... ... Letters—for Temperature, Humidity and other Controlled Environments” , ... (Vocus) April 29, 2010 -- ... and other Controlled Environments” is now available from Veriteq ( www.veriteq.com ), ...
... beneficial, researchers say , THURSDAY, April 29 (HealthDay News) ... deep brain stimulation surgery in addition to treatment with ... the procedure, patients who underwent the surgery reported better ... and engage in routine daily activities compared to those ...
... , ... is a saying that seems to ring true according to husbands whose wives have had ... Surgery takes a look at the transformative journey from the husband,s perspective. , ... Newport Beach, Calif (Vocus) April 29, 2010 ...
... ... NeverTouch® laser fiber , ... Albany, N.Y. (PRWEB) April 29, 2010 -- AngioDynamics (NASDAQ: ANGO) announced today that ... expected to be featured in a segment on the popular television show "The Doctors.", ...
... ... of pool security results in the death of 100’s of children around the world. Despite it ... posing a serious risk. , ... 29, 2010 -- Du Toit & Associates plead to all swimming pool owners to follow swimming ...
... ... Awareness of Symptoms of Brain Aneurysms , ... Boston, MA (PRWEB) April 29, 2010 - On April 23, ... Seventy to eighty percent of spontaneous subarachnoid hemorrhages are caused by ruptured cerebral ...
Cached Medicine News:Health News:Guide for US FDA-Regulated Organizations Now Available 2Health News:Guide for US FDA-Regulated Organizations Now Available 3Health News:Adding Surgery to Meds May Improve Life With Parkinson's 2Health News:Cruise Plastic Surgery Looks at Mommy Makeovers from the Husband's Perspective and Offers Tips 2Health News:Cruise Plastic Surgery Looks at Mommy Makeovers from the Husband's Perspective and Offers Tips 3Health News:Cruise Plastic Surgery Looks at Mommy Makeovers from the Husband's Perspective and Offers Tips 4Health News:AngioDynamics' VenaCure EVLTTM System for Varicose Veins To Be Featured On 'The Doctors' National Television Program 2Health News:AngioDynamics' VenaCure EVLTTM System for Varicose Veins To Be Featured On 'The Doctors' National Television Program 3Health News:AngioDynamics' VenaCure EVLTTM System for Varicose Veins To Be Featured On 'The Doctors' National Television Program 4Health News:Du Toit & Associates Prepare to Prevent Silent Deaths by the Pool this Summer 2Health News:Early Detection Makes a Difference in the Treatment of Brain Aneurysms 2Health News:Early Detection Makes a Difference in the Treatment of Brain Aneurysms 3
A single tube that performs two rapid tests for E. coli from culture. ColiScreen™ combines both the indole test with the glucuronidase test to increase the specificity....
Legionella provides rapid, accurate results that aid in the presumptive diagnosis of Legionella infection (Legionnaires' Disease)....
... Captia™ Legionella pneumophila IgG/IgM Enzyme-Linked ... for the qualitative detection of ... to Legionella pneumophila (Legionella) serogroups ... with clinical suspicion of Legionella ...
The GoodKnight® 425 Bi-Level® device is suitable for travel and includes features such as automatic altitude compensation, optional cigarette lighter adapter and portable battery pack...
Medicine Products: